TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Sanofi AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
898,816
|
754,331
|
830,858 |
| Financial expenses |
105
|
936
|
352 |
| Earnings before taxes |
25,556
|
36,677
|
43,644 |
| EBITDA |
25,973
|
37,563
|
47,925 |
| Total assets |
521,909
|
371,874
|
433,228 |
| Current assets |
516,850
|
366,990
|
433,140 |
| Current liabilities |
420,154
|
261,309
|
277,163 |
| Equity capital |
88,382
|
97,261
|
142,081 |
| - share capital |
1,767
|
1,757
|
1,912 |
| Employees (average) |
122
|
144
|
154 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
16.9%
|
26.2%
|
32.8% |
| Turnover per employee |
7,367
|
5,238
|
5,395 |
| Profit as a percentage of turnover |
2.8%
|
4.9%
|
5.3% |
| Return on assets (ROA) |
4.9%
|
10.1%
|
10.2% |
| Current ratio |
123.0%
|
140.4%
|
156.3% |
| Return on equity (ROE) |
28.9%
|
37.7%
|
30.7% |
| Change turnover |
140,600
|
-9,227
|
89,584 |
| Change turnover % |
19%
|
-1%
|
12% |
| Chg. No. of employees |
-22
|
-10
|
3 |
| Chg. No. of employees % |
-15%
|
-6%
|
2% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.